X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (88) 88
oncology (70) 70
index medicus (55) 55
female (37) 37
cancer (36) 36
male (35) 35
chemotherapy (30) 30
lung neoplasms - drug therapy (30) 30
carcinoma, non-small-cell lung - drug therapy (27) 27
care and treatment (27) 27
antineoplastic agents - therapeutic use (26) 26
lung cancer (26) 26
middle aged (26) 26
aged (24) 24
lung cancer, non-small cell (24) 24
adult (23) 23
immunotherapy (22) 22
treatment outcome (21) 21
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
research (19) 19
health aspects (18) 18
lung neoplasms - pathology (17) 17
animals (16) 16
non-small cell lung cancer (16) 16
bevacizumab (15) 15
carcinoma, non-small-cell lung - pathology (15) 15
respiratory system (15) 15
clinical trials (14) 14
medicine, research & experimental (14) 14
nsclc (14) 14
lung neoplasms - therapy (13) 13
combined modality therapy (12) 12
medicine, general & internal (12) 12
prognosis (12) 12
tumors (12) 12
1st-line treatment (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
carcinoma, non-small-cell lung - therapy (11) 11
cetuximab (11) 11
clinical trials as topic (11) 11
disease-free survival (11) 11
erlotinib (11) 11
lung neoplasms - genetics (11) 11
solid tumors (11) 11
survival (11) 11
antineoplastic agents - pharmacology (10) 10
docetaxel (10) 10
drug therapy (10) 10
expression (10) 10
gefitinib (10) 10
hematology, oncology and palliative medicine (10) 10
non-small-cell lung cancer (10) 10
open-label (10) 10
phase-ii trial (10) 10
targeted therapy (10) 10
antibodies, monoclonal - therapeutic use (9) 9
antimitotic agents (9) 9
antineoplastic agents (9) 9
development and progression (9) 9
epidermal growth factor (9) 9
head and neck cancer (9) 9
metastasis (9) 9
pharmacology & pharmacy (9) 9
physiological aspects (9) 9
randomized-trial (9) 9
review (9) 9
squamous-cell carcinoma (9) 9
taxoids - administration & dosage (9) 9
trial (9) 9
tyrosine kinase inhibitor (9) 9
aged, 80 and over (8) 8
antineoplastic agents - adverse effects (8) 8
cancer vaccines - therapeutic use (8) 8
carcinoma, non-small-cell lung - genetics (8) 8
carcinoma, non-small-cell lung - immunology (8) 8
cisplatin (8) 8
dosage and administration (8) 8
health care sciences & services (8) 8
lung neoplasms - immunology (8) 8
lung neoplasms - metabolism (8) 8
medicine & public health (8) 8
phase-ii (8) 8
phase-iii (8) 8
radiotherapy (8) 8
bortezomib (7) 7
cancer vaccines (7) 7
carcinoma, non-small-cell lung - metabolism (7) 7
cell lung-cancer (7) 7
genetic aspects (7) 7
head and neck neoplasms - drug therapy (7) 7
health policy & services (7) 7
lung-cancer (7) 7
medical ethics (7) 7
medical laboratory technology (7) 7
medicine, legal (7) 7
paclitaxel (7) 7
pemetrexed (7) 7
protein kinase inhibitors - therapeutic use (7) 7
public, environmental & occupational health (7) 7
squamous cell carcinoma (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, ISBN 9780702028892, xxi, 256
Book
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e13582 - e13582
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e13558 - e13558
Journal Article
Targeted Oncology, ISSN 1776-2596, 10/2018, Volume 13, Issue 5, pp. 541 - 544
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11523-018-0593-y 
CELL LUNG-CANCER | MULTIPLE-MYELOMA | SURVIVAL | METASTATIC MELANOMA | SOLID TUMORS | ONCOLOGY | MICROSATELLITE INSTABILITY | LONG-TERM SAFETY | PAPILLARY THYROID-CANCER | BRAF V600E MUTATION | COLORECTAL-CARCINOMA | Antimitotic agents | Care and treatment | Drug therapy | Antineoplastic agents | Health aspects | Cancer | Targeted cancer therapy
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e18665 - e18665
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e18113 - e18113
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e24318 - e24318
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e24288 - e24288
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 06/2019, Volume 19, Issue 6, pp. 509 - 515
Introduction: The systemic treatment of non-small cell lung cancer (NSCLC) has changed dramatically with the identification of actionable mutations and the use... 
CTLA-4 | biomarkers | Non-small cell lung cancer | immunotherapy | MEDICINE, RESEARCH & EXPERIMENTAL | CTLA-4 BLOCKADE | 1ST-LINE TREATMENT | IMMUNE CHECKPOINT INHIBITORS | METASTATIC MELANOMA | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | EXPANDED ACCESS PROGRAM | PHASE-I | CLINICAL-RESPONSE | PLUS IPILIMUMAB | ADVERSE EVENTS | T-CELLS
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e18239 - e18239
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 11550 - 11550
Journal Article
Oncotarget, ISSN 1949-2553, 04/2019, Volume 10, Issue 30, p. 2911
Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer and its molecular landscape has been extensively studied. The most common genetic... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2016, Volume 34, Issue 7_suppl, pp. 51 - 51
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.